Link to this page
Biological and Environmental Research Ontology
Last uploaded:
December 23, 2022
| Id | http://purl.obolibrary.org/obo/NCIT_C1423
http://purl.obolibrary.org/obo/NCIT_C1423
|
|---|---|
| Preferred Name | Perfosfamide |
| Definitions |
The active metabolite of the nitrogen mustard cyclophosphamide with potent antineoplastic and immunosuppressive properties. Perfosfamide alkylates DNA, thereby inhibiting DNA replication and RNA and protein synthesis. (NCI04)
|
| Type | http://www.w3.org/2002/07/owl#Class |
All Properties
| definition | The active metabolite of the nitrogen mustard cyclophosphamide with potent antineoplastic and immunosuppressive properties. Perfosfamide alkylates DNA, thereby inhibiting DNA replication and RNA and protein synthesis. (NCI04) |
|---|---|
| prefLabel | Perfosfamide
|
| label | Perfosfamide
|
| CHEBI_ID | CHEBI:196991
|
| PDQ_Closed_Trial_Search_ID | 40474
|
| code | C1423
|
| prefixIRI | NCIT:C1423
|
| in_subset | |
| Preferred_Name | Perfosfamide
|
| FDA_UNII_Code | U880A4FUDA
|
| Contributing_Source | FDA
|
| Chemical_Formula | C7H15Cl2N2O4P
|
| Maps_To | Perfosfamide
|
| CAS_Registry | 39800-16-3
|
| NSC Number | 181815
|
| NCI_Drug_Dictionary_ID | 40474
|
| Legacy Concept Name | Perfosfamide
|
| type | |
| Is_Value_For_GDC_Property | |
| subClassOf | |
| PDQ_Open_Trial_Search_ID | 40474
|
| Accepted_Therapeutic_Use_For | Ex-vivo treatment of autologous bone marrow and subsequent reinfusion in patients with acute myelogenous leukemia
|
| Semantic_Type |
Organic Chemical
Pharmacologic Substance
|
| UMLS_CUI | C0163054
|
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |